Sarepta
Rare Disease Therapeutics · Cell & Gene Therapy

Sarepta news and milestones

Sarepta: 16 headlines on record, 8 headlines in the last 90 days. Its story counts 1 milestone.

Data updated Nov 18, 2026 · Back to the company report
16Headlines
8In 90 days
1Milestones

Headlines

Oct 22026
News · BioSpace
Jefferies analysts made the prediction after Sarepta Therapeutics, which has endured nothing short of a saga with the Duchenne muscular dystrophy gene therapy Elevidys, presented…
Sep 302026
News · Sarepta Therapeutics stock falls 1.28 percent as DMD data land
Sarepta Therapeutics stock posted Q2 revenue of USD 401.25 million and EPS of USD 0.64 on August 5, 2026. ELEVIDYS data covered older patients at the September 30 congress.
Sep 262026
News · YahooFinance
In September 2026, REGENXBIO and the University of Pennsylvania settled their patent infringement litigation with Sarepta Therapeutics and Catalent over ELEVIDYS, with Sarepta ag…
Sources: the outlets named on each headline, each story once

Milestones

Each milestone is dated by its source: registers, filings, the press

How to cite

Sarepta, News. Alion, Nov 18, 2026. https://alion.io/company/sarepta/news

.json · .md · CC BY-SA 4.0